Aside from ALCL, Voorhees, et al., reported durable CR after CD30-CAR T in a patient with heavily pre-treated CD30+ enteropathy-associated T-cell lymphoma (214). Here, TNFRSF8 is linked to T-cell non-Hodgkin lymphoma.